Actively Recruiting
Study to Identify Immune and Imaging Factors Predicting Progression in Moderate Aortic Valve Stenosis
Led by Heinrich-Heine University, Duesseldorf · Updated on 2026-06-30
938
Participants Needed
3
Research Sites
260 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying moderate aortic valve stenosis, focusing on understanding the biological markers and mechanisms that influence disease progression. The study aims to identify patients at high risk for severe aortic stenosis and to explore potential new treatments. This observational research is part of a larger collaborative project among three universities and involves examining genetic, immune, and imaging factors that may predict how the condition worsens over time. Participants will be observed without receiving specific treatments as this is an observational study. The study involves collecting multiple types of information including imaging, genetic testing, and immune system assessments to monitor disease development. The plan is to follow 938 patients with moderate aortic stenosis over several years to gather data that may help predict disease progression. Throughout the study, participants will have regular clinical assessments including imaging scans and evaluations of heart function. Researchers will track outcomes such as the worsening of aortic stenosis, hospitalizations, heart attacks, strokes, and mortality over a five-year period. The study will last until 2031, allowing long-term observation of the diseases natural course and its impact on participants health.
CONDITIONS
Brief Title
Mechanisms Of Disease Progression in Aortic Stenosis - the MODAS Study
Research Team
T
Tobias Zeus, MD
L
Lisa Dannenberg, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here